메뉴 건너뛰기




Volumn 32, Issue 8, 2005, Pages 2496-2502

Prescription dose in permanent 131Cs seed prostate implants

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; TUMORS;

EID: 23944439367     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1951062     Document Type: Article
Times cited : (15)

References (20)
  • 3
    • 0028919251 scopus 로고
    • Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM radiation therapy committee task group no. 43
    • R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM radiation therapy committee task group no. 43," Med. Phys. 22, 209-234 (1995).
    • (1995) Med. Phys. , vol.22 , pp. 209-234
    • Nath, R.1    Anderson, L.L.2    Luxton, G.3    Weaver, K.A.4    Williamson, J.F.5    Meigooni, A.S.6
  • 4
    • 0032891406 scopus 로고    scopus 로고
    • Guidance to users of Nycorred Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Associate of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry
    • J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. Ibbott, "Guidance to users of Nycorred Amersham and North American Scientific, Inc., I-125 interstitial sources: Dosimetry and calibration changes: Recommendations of the American Associate of Physicists in Medicine Radiation Therapy Committee Ad Hoc Subcommittee on Low-Energy Seed Dosimetry," Med. Phys. 26, 570-573 (1999).
    • (1999) Med. Phys. , vol.26 , pp. 570-573
    • Williamson, J.F.1    Coursey, B.M.2    Dewerd, L.A.3    Hanson, W.F.4    Nath, R.5    Ibbott, G.6
  • 7
    • 0026651166 scopus 로고
    • Permanent implants using Au-198, Pd-103, and I-125: Radiobiological considerations based on the linear quadratic model
    • C. C. Ling, "Permanent implants using Au-198, Pd-103, and I-125: Radiobiological considerations based on the linear quadratic model," Int. J. Radiat. Oncol., Biol., Phys. 23, 81-87 (1992).
    • (1992) Int. J. Radiat. Oncol., Biol., Phys. , vol.23 , pp. 81-87
    • Ling, C.C.1
  • 8
    • 0037035357 scopus 로고    scopus 로고
    • 103Pd prostate permanent seed implants - A biomathematical model
    • 103Pd prostate permanent seed implants-A biomathematical model," Phys. Med. Biol. 47, 1185-1204 (2002).
    • (2002) Phys. Med. Biol. , vol.47 , pp. 1185-1204
    • Yue, N.J.1    Chen, Z.2    Nath, R.3
  • 9
    • 0021812109 scopus 로고
    • The application of the linear-qualratic dose-effect equation to fractionated and protracted radiotherapy
    • R. G. Dale, "The application of the linear-qualratic dose-effect equation to fractionated and protracted radiotherapy," Br. J. Radiol. 58, 515-528 (1985).
    • (1985) Br. J. Radiol. , vol.58 , pp. 515-528
    • Dale, R.G.1
  • 10
    • 0024550508 scopus 로고
    • Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model
    • R. G. Dale, "Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model," Br. J. Radiol. 62, 241-244 (1989).
    • (1989) Br. J. Radiol. , vol.62 , pp. 241-244
    • Dale, R.G.1
  • 11
    • 0018320349 scopus 로고
    • Dose-rate effects in mammalian cells in culture. III Comparison of cell killing and cell lines
    • J. B. Mitchell, J. S. Bedford, and S. M. Barley, "Dose-rate effects in mammalian cells in culture. III Comparison of cell killing and cell lines," Radiat. Res. 79, 537-551 (1979).
    • (1979) Radiat. Res. , vol.79 , pp. 537-551
    • Mitchell, J.B.1    Bedford, J.S.2    Barley, S.M.3
  • 13
    • 0032527941 scopus 로고    scopus 로고
    • 103Pd prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition
    • 103Pd prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition," Int. J. Radiat. Oncol., Biol., Phys. 41, 1069-1077 (1998).
    • (1998) Int. J. Radiat. Oncol., Biol., Phys. , vol.41 , pp. 1069-1077
    • Waterman, F.M.1    Yue, N.2    Corn, B.W.3    Dicker, A.P.4
  • 15
    • 0032520996 scopus 로고    scopus 로고
    • Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy
    • B. R. Prestidge, W. S. Bice, E. J. Kiefer, and J. J. Prete, "Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 40, 1111-1115 (1998).
    • (1998) Int. J. Radiat. Oncol., Biol., Phys. , vol.40 , pp. 1111-1115
    • Prestidge, B.R.1    Bice, W.S.2    Kiefer, E.J.3    Prete, J.J.4
  • 16
    • 0031950541 scopus 로고    scopus 로고
    • Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy
    • G. S. Merrick, W. M. Butler, A. T. Dorsey, and H. L. Walbert, "Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy," Radiat. Oncol. Invest. 6, 182-190 (1998).
    • (1998) Radiat. Oncol. Invest. , vol.6 , pp. 182-190
    • Merrick, G.S.1    Butler, W.M.2    Dorsey, A.T.3    Walbert, H.L.4
  • 17
    • 0141576615 scopus 로고    scopus 로고
    • The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?
    • J. Z. Wang, X. A. Li, C. X. Yu, and S. J. DiBiase, "The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?" Int. J. Radiat. Oncol., Biol., Phys. 57, 1101-1108 (2003).
    • (2003) Int. J. Radiat. Oncol., Biol., Phys. , vol.57 , pp. 1101-1108
    • Wang, J.Z.1    Li, X.A.2    Yu, C.X.3    DiBiase, S.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.